NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/09/2023
Voltar para busca
Dado oficial do USPTO
EIRGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
26/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
26/04/2022
Data de registro
26/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/09/2023
Última transação
26/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Waterford, IE
Examinador
MAJCHER HARTNETT, MEGAN
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EirGen Pharma Limited
Representantes
Sean P. McMahon SEAN P. MCMAHON, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industryscience and photography; chemical substances for preserving foodstuffs; adhesives used in industry; biological preparations for use in biotechnology other than for medical use
Classe 5
Pharmaceutical preparations and substances for the treatment of medical ailments and medical conditionscardiovascular and central nervous system disordersmalignant diseases and immunosuppressionmusculoskeletal and joint diseasesoculargynecological and urinary tract disorders and infectious and non-infectious diseases; sanitary preparations for medical use; prescription pharmaceutical and biotechnological preparations for the treatment of medical ailments and medical conditionscardiovascular and central nervous system disordersmalignant diseases and immunosuppression musculoskeletal and joint diseasesoculargynecological and urinary tract disorders and infectious and non-infectious diseases; biological preparations for medical purposesfor use in biotechnology for the treatment of cancerinfectious diseasesmetabolic diseases and disorders; chemical preparations and reagents for use in biotechnology for medical and veterinary userenal diseases and disorderscognitive and neurological disordersvitamin D insufficienciescancer and infectious diseases; injectable solutions for medical purposesinjectable pharmaceuticals for cardiovascular and central nervous system disordersmalignant diseases and immunosuppressionmusculoskeletal and joint diseasesoculargynecological and urinary tract disorders; dietetic foodspastacrackersbreadfood supplementsinfusionsdrinks and beverages all adapted for medical use; all purpose disinfectantsoral disinfectants for medical and hygienic purposesdisinfectants for hygienic and sanitary purposesdisinfectants for medical instruments; syrups for pharmaceutical purposescough syrups; vaccines; syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disordersmalignant diseases and immunosuppressionmusculoskeletal and joint diseasesoculargynecological and urinary tract disorders for medical use; pre-filled disposable syringes and hypodermic syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disordersmalignant diseases and immunosuppressionmusculoskeletal and joint diseasesoculargynecological and urinary tract disorders for medical use
Classe 42
The provision of information on the subject of research and developmentdrug development and product evaluation all in the field of pharmaceuticals and biotechnology; scientific and industrial research relating to pharmaceuticals and biotechnology
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2023
PUBO
PUBLISHED FOR OPPOSITION
11/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/06/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/06/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/05/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
15/05/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
15/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/02/2023
GNRT
NON-FINAL ACTION E-MAILED
13/02/2023
CNRT
NON-FINAL ACTION WRITTEN
13/02/2023
DOCK
ASSIGNED TO EXAMINER
13/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2022
NWAP
NEW APPLICATION ENTERED
29/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EIRGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.